Stock listing

KRX:475960 Tomocube, Inc. (토모큐브) 주가

Follow Tomocube, Inc. into a list and get an email when it puts out news.

Share price · KRX:475960

₩20,950 KRW -1,350 (-6.1%)

Close on Nov 20, 2026

Past year -51.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩20,650 – ₩22,000 KRWNov 20, 2026
Volume
48,617 sharesNov 20, 2026
Market cap
₩280.4B KRWAt the close on Nov 20, 2026 · price × 13.38M shares outstanding
52-week range
₩20,650 – ₩67,800 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩1.27B KRWMedian day 32,775 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Tomocube, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:475960 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩20,950-1,350-6.1%₩22,000₩22,000₩20,65048,617
₩22,300-600-2.6%₩22,950₩23,450₩20,950127,318
₩22,900-1,800-7.3%₩24,100₩24,500₩22,15079,686
₩24,700-700-2.8%₩25,650₩25,650₩24,10033,700
₩25,400-3,050-10.7%₩28,350₩29,350₩24,500139,051
₩28,450-500-1.7%₩28,500₩29,050₩27,70028,646
₩28,950+2,800+10.7%₩26,150₩30,600₩26,150113,666
₩26,150+650+2.5%₩26,500₩26,800₩25,30039,813
₩25,500+650+2.6%₩25,250₩26,100₩24,35028,551
₩24,850-1,950-7.3%₩24,700₩26,150₩23,30037,101
₩26,800-700-2.5%₩28,150₩28,550₩26,70031,785
₩27,500-1,100-3.8%₩29,000₩29,350₩26,30062,313
₩28,600-1,000-3.4%₩29,600₩29,700₩28,40018,804
₩29,600-900-3.0%₩30,400₩30,450₩29,40018,544
₩30,500-2,150-6.6%₩31,150₩31,750₩29,70031,979
₩32,650+700+2.2%₩31,950₩34,150₩31,55053,971
₩31,950+550+1.8%₩31,500₩32,100₩30,45032,343
₩31,400+50+0.2%₩31,650₩33,000₩31,35036,811
₩31,350+1,250+4.2%₩30,100₩32,500₩29,50048,475
₩30,100-300-1.0%₩29,700₩30,300₩28,60021,031
₩30,400-700-2.3%₩31,000₩31,300₩30,05016,885
₩31,100+600+2.0%₩30,600₩31,750₩30,60023,178
₩30,500-1,000-3.2%₩31,200₩31,500₩30,05018,919
₩31,500+250+0.8%₩29,850₩31,500₩29,80032,427
₩31,250+2,250+7.8%₩29,050₩31,750₩29,05030,045
₩29,000-2,200-7.1%₩30,000₩30,300₩28,30044,755
₩31,200-50-0.2%₩31,450₩32,400₩30,60033,320
₩31,250-1,050-3.3%₩31,400₩31,800₩30,35046,798
₩32,300-950-2.9%₩32,850₩33,700₩32,00039,250
₩33,250-1,250-3.6%₩33,950₩35,550₩33,20048,341
₩34,500-1,400-3.9%₩36,450₩36,450₩33,85066,040
₩35,900+1,600+4.7%₩35,000₩36,500₩34,65041,765
₩34,300-2,650-7.2%₩36,900₩36,900₩34,05074,412
₩36,950+1,950+5.6%₩34,800₩37,500₩33,90086,298
₩35,000+3,200+10.1%₩32,000₩36,450₩32,000113,951
₩31,800+450+1.4%₩30,650₩32,550₩29,80053,784
₩31,350+3,500+12.6%₩28,800₩32,600₩28,500138,115
₩27,850+550+2.0%₩27,400₩28,050₩27,25015,718
₩27,300-300-1.1%₩27,700₩28,100₩27,05014,562
₩27,600+50+0.2%₩27,400₩27,850₩26,90014,412
₩27,550-500-1.8%₩28,100₩28,200₩27,30019,535
₩28,050+550+2.0%₩27,300₩28,350₩27,30014,452
₩27,500+650+2.4%₩26,700₩27,600₩26,00031,863
₩26,850+100+0.4%₩27,000₩27,400₩26,35015,238
₩26,750-500-1.8%₩27,250₩27,350₩26,35028,555
₩27,250-400-1.4%₩27,050₩27,800₩26,80017,104
₩27,650-800-2.8%₩27,900₩28,000₩27,10024,094
₩28,450-150-0.5%₩28,150₩29,000₩28,15011,407
₩28,600+400+1.4%₩29,000₩29,300₩28,35022,388
₩28,200+100+0.4%₩28,400₩28,900₩27,10031,530
₩28,100+850+3.1%₩27,250₩28,600₩26,30033,765
₩27,250-1,350-4.7%₩29,400₩29,400₩26,65050,998
₩28,600-850-2.9%₩28,800₩29,250₩28,30021,240
₩29,450-1,050-3.4%₩30,500₩30,700₩29,00033,300
₩30,500+450+1.5%₩29,800₩30,500₩28,80032,733
₩30,050-750-2.4%₩31,850₩31,850₩29,90023,224
₩30,800-1,100-3.4%₩31,900₩31,900₩30,55022,774
₩31,900+650+2.1%₩31,500₩32,200₩31,20026,169
₩31,250-1,250-3.8%₩32,000₩32,550₩30,25032,816
₩32,500+3,650+12.7%₩29,350₩32,950₩29,15065,653
₩28,850-1,950-6.3%₩30,500₩30,500₩28,75061,054
₩30,800-750-2.4%₩32,100₩33,750₩30,60051,390
Ticker
KRX:475960
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
KRX
Currency
KRW

Tomocube, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
Decks
4 decks · latest May 30, 2025

Valuation

EV/sales 16.6× against a median of 3.8×: 10th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩252.0B KRW
P/E
Loss
EV/sales
16.6×
EV/EBITDA
Negative EBITDA
Price/book
7.4×
Gross margin
64.5%
Operating margin
−25.5%
Net margin
−16.1%
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Tomocube, Inc. · KRX:475960US$208.3MUS$187.2Mn/a16.6×n/a7.4×−16.1%0.0×n/a
Jiangsu Cowin Biotech Co., Ltd. Class A · SSE:688426US$250.1MUS$138.3Mn/a4.0×n/a1.3×−35.4%0.0×n/a
Lifecore Biomedical, Inc. · NASDAQ:LFCRUS$242.2MUS$380.1Mn/a2.9×46.1×n/a−23.8%n/a0.51
OraSure Technologies, Inc. · NASDAQ:OSURUS$238.9MUS$102.3Mn/a0.9×n/a0.8×−41.7%0.0×1.21
Shanghai Rendu Biotechnology Co., Ltd. Class A · SSE:688193US$216.7MUS$100.3M64.7×4.2×n/a1.6×13.9%0.0×n/a
Median Technologies · EURONEXT:ALMDTUS$214.8MUS$176.5Mn/a6.9×n/an/a−145.8%n/an/a
Guangzhou LBP Medicine Science & Technology Co., Ltd. Class A · SSE:688393US$195.9MUS$151.2Mn/a2.8×n/a1.2×−9.2%0.0×n/a
Dishman Carbogen Amcis Ltd. · NSE:DCALUS$195.5MUS$195.5M26.6×0.8×4.2×0.3×3.0%0.0×n/a
Quantum-Si Incorporated · NASDAQ:QSIUS$180.8MUS$80.11Mn/a63.3×n/a1.1×n/a0.0×3.19
Tarsons Products Limited · NSE:TARSONSUS$174.2MUS$174.2M146×3.7×13.5×2.5×2.5%0.0×n/a
AVE Science & Technology Co., Ltd. Class A · SSE:688067US$170.2MUS$138.2M33.8×3.9×n/a2.1×14.3%0.0×n/a
Median of the othersUS$205.4MUS$144.8M49.2×3.8×13.5×1.2×−9.2%0.0×1.21

Forecasts

Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.

EPS, year to Dec 2026
271.00 · 1 analyst
Revenue, year to Dec 2026
23B · 1 analyst

Team and board

Officers

OfficerRole
YongKeun ParkChief Executive Officer, Chair of the Board of Directors
SungHo KoChief Operating Officer, Director

Board

DirectorRole
Bernard K. HamDirector
Sang-Hoon ChaDirector
Sang-il ParkDirector
SungHo KoChief Operating Officer, Director

Decks

DeckKindSlidesDate
Q1 2025 Earnings PresentationEarnings39 slidesMay 30, 2025
Q1 2025 Earnings PresentationEarnings40 slidesMay 23, 2025
Investor Presentation (December 2024)Investor deck43 slidesDec 5, 2024
Investor Presentation (October 2024)Investor deck46 slidesOct 15, 2024

Open Decks

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue11.3B5.94B3.75B1.87B1.63B
Cost of revenue3.86B2.35B1.57B928.4M959.1M
Gross profit7.44B3.59B2.18B942.7M666.1M
Research and development5.22B5.47B3.67B3.24B3.77B
Selling, general and administrative2.83B6.26B4.76B3.84B828.5M
Operating income-5.57B-8.78B-6.73B-6.37B-6.41B
Depreciation and amortization1.51B1.07B1.02B611.2M596.6M
EBITDA-4.06B-7.70B-5.71B-5.76B-5.81B
Interest expense72.2M65.9M5.12B4.34B2.77B
Income before tax-4.81B-8.30B-23.6B29.3B-19.3B
Net income-4.81B-8.30B-23.6B29.3B-19.3B
Earnings per share, basic-359.40-636.32-1,849.802,304.29-1,813.18

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents11.4B12.7B2.85B1.53B18.2B
Short-term investments17.2B23.0B9.49B17.2B8.02B
Receivables2.87B1.49B1.01B336.9M243.3M
Inventory3.59B2.38B2.27B2.79B1.07B
Current assets35.7B40.1B16.0B22.1B27.7B
Property, plant and equipment2.85B3.14B2.23B
Total assets41.5B43.6B19.8B25.1B30.0B
Accounts payable276.7M21.1M59.7M251.2M261.1M
Current liabilities1.54B1.33B1.78B52.2B87.8B
Long-term debt00300.0M
Total liabilities2.72B1.62B2.07B52.9B88.2B
Shareholders' equity38.8B42.0B17.7B-27.8B-58.3B
Shares outstanding13.4M13.0M12.7M12.7M10.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-6.75B-6.54B-5.93B-6.75B-4.42B
Capital spending-773.6M-934.3M-231.5M-568.9M-645.6M
Free cash flow-7.53B-7.47B-6.16B-7.32B-5.07B
Cash from investing-14.4B7.47B-9.77B
Cash from financing30.7B-182.2M-156.6M
Share buybacks33.3B
Change in cash-1.24B9.84B1.33B-16.7B8.07B

Open Financials

Cap table

Built by 6ix from Tomocube, Inc.’s releases

Common shares
13,383,274
Fully diluted
13,383,274

Fully diluted

LineShares
Common shares13,383,274

Share count over time

CountShares
Nov 22, 202613,383,274

Open Cap table

Shareholders

HolderSharesValueAs of
State Street(R) SPDR(R) S&P(R) International Small Cap ETF7,087US$167KJun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bernard K. HamDirector · Since at least Nov 5, 2026
Sang-Hoon ChaDirector · Since at least Nov 5, 2026
Sang-il ParkDirector · Since at least Nov 5, 2026
SungHo KoChief Operating Officer, Director · Since at least Nov 5, 2026
YongKeun ParkChief Executive Officer, Chair of the Board of Directors · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Tomocube, Inc.